The investigators designed a multicentral, observational, prospective cohort study to provide cortical data for risk stratification and biomarkers on early outcomes, complications, long-term neurological function, and cognitive status of spontaneous intracerebral hemorrhage patients.
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
* Diagnosed with spontaneous intracerebral hemorrhage (ICH) through skull radiologic scans (CT or MRI);
* Underwent no surgical intervention;
Exclusion Criteria:
* Secondary intracerebral hemorrhage (with leading cause, e.g., Moyamoya disease, arteriovenous malformation, intracranial aneurysm, tumor, brain trauma)
* Pre-stroke life expectancy \< 1 year for severe comorbidities (e.g., Progressive malignant tumor, severe chronic heart failure \[NYHA: III-IV\], severe chronic obstructive pulmonary disease \[III-IV\], chronic kidney disease requiring hemodialysis)
* Severe dependency or incorporation to interview (e.g., pre-stroke mRS\>3, severe dementia, intractable mental disease)
* Unsuitable for inclusion in the study in the opinion of the investigator
Primary outcome measure(s)
Neurological Function — Discharge; 3, 6, 12 months after enrollment Assessed with modified Rankin Scale (0-6)
Mortality — Discharge; 3, 6, 12 months after enrollment
Trial sites (6)
Facility
City
Region
Status
First Affiliated Hospital of Fujian Medical University
Fuzhou
Fujian
Recruiting
Anxi County Hospital
Quanzhou
Fujian
Recruiting
Jinjiang Municipal Hospital
Quanzhou
Fujian
Recruiting
The Second Affiliated lospital of Xiamen Medical College
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.